↓ Skip to main content

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer

Overview of attention for article published in Cancer Research and Treatment : Official Journal of Korean Cancer Association, March 2018
Altmetric Badge

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
Published in
Cancer Research and Treatment : Official Journal of Korean Cancer Association, March 2018
DOI 10.4143/crt.2018.019
Pubmed ID
Authors

Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, Keunchil Park, Hoon-Kyo Kim, Joung Soon Jang, Bong-Seog Kim, Jin-Hyoung Kang, Kyung Hee Lee, Sang-We Kim, Hun Mo Ryoo, Jin-Soo Kim, Ki Hyeong Lee, Jung Hye Kwon, Jin-Hyuk Choi, Sang Won Shin, Seokyung Hahn, Dae Seog Heo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Bachelor 5 10%
Researcher 5 10%
Lecturer 3 6%
Professor 3 6%
Other 9 17%
Unknown 21 40%
Readers by discipline Count As %
Medicine and Dentistry 13 25%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Nursing and Health Professions 3 6%
Sports and Recreations 2 4%
Neuroscience 2 4%
Other 4 8%
Unknown 23 44%